Barclays Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $96

巴克萊銀行維持大都會人壽(MET.US)買入評級，維持目標價96美元

moomoo資訊 · 01/07 01:34 · 評級/大行評級

Barclays analyst Alex Scott maintains $MetLife (MET.US)$ with a buy rating, and maintains the target price at $96.

According to TipRanks data, the analyst has a success rate of 57.1% and a total average return of 10.6% over the past year.

AnalystRecentRatingAutoNews_202978_20250107_a792f60488354b9d72ed8cfc371075298a2989ec_1736328616742626_mm_en

Furthermore, according to the comprehensive report, the opinions of $MetLife (MET.US)$'s main analysts recently are as follows:

The long-term fundamental outlook for the life insurance sector is seen as downbeat, yet the near-term prospects for stocks remain positive. Factors such as a favorable macroeconomic environment, strong balance sheets, and the capacity for share buybacks among insurers, along with current valuations, are anticipated to support further outperformance in life insurance stocks. However, a potential decline in corporate credit is viewed as a significant risk to this optimistic view.
The outlook for the insurance industry as we approach 2025 includes a more positive view on life insurers, credited to improving free cash flow, benefits derived from higher interest rates, substantial excess capital positions, robust group benefits earnings, and the potential for additional reinsurance and merger activities. Although the property and casualty sector maintains long-term quality, current challenges in property coverage underwriting and casualty loss cost trends present risks that could deter more favorable developments. Consequently, selectivity in stock selections is advised.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

巴克萊銀行分析師Alex Scott維持$大都會人壽 (MET.US)$買入評級，維持目標價96美元。

根據TipRanks數據顯示，該分析師近一年總勝率為57.1%，總平均回報率為10.6%。

AnalystRecentRatingAutoNews_202978_20250107_a792f60488354b9d72ed8cfc371075298a2989ec_1736328616742626_mm_tc

此外，綜合報道，$大都會人壽 (MET.US)$近期主要分析師觀點如下：

人壽保險行業的長期基本面前景被視爲悲觀，但股票的短期前景仍然樂觀。有利的宏觀經濟環境、強勁的資產負債表和保險公司的股票回購能力等因素以及當前的估值預計將支持人壽保險股的進一步跑贏大盤。但是，企業信貸的潛在下降被視爲這種樂觀觀點的重大風險。
臨近2025年，保險業的前景包括對人壽保險公司的更加樂觀的看法，這要歸功於自由現金流的改善、更高的利率所帶來的好處、大量的過剩資本狀況、強勁的集團福利收益以及額外的再保險和合並活動的可能性。儘管財產和意外傷害行業保持了長期質量，但當前在財產保險承保和意外傷害損失成本趨勢方面的挑戰所帶來的風險可能會阻礙更有利的發展。因此，建議選擇股票。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Barclays Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $96

Barclays Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $96

風險及免責聲明

聲明